Interwell 360
Comprehensive kidney care management platform for patients, providers, and payers
Platform · Cloud SaaSCompany source
Company profile
About Cricket Health
Interwell Health is a kidney care management company that partners with physicians on its mission to reimagine healthcare with the expertise, compassion, and vision to set the standard for the industry and help patients live their best lives. The company was formed in August 2022 through the merger of three industry leaders: Fresenius Health Partners, Interwell Health, and Cricket Health, bringing together value-based care expertise, an unrivaled network of physician partners, and innovative data and analytics capabilities. In September 2022, Interwell Health further expanded its capabilities with the acquisition of Acumen Physician Solutions, the leading provider of electronic health record and patient management software designed for nephrologists. Interwell Health operates a comprehensive value-based kidney care model that serves patients, providers, and payers. The company manages over 160,000 lives across all 50 states through partnerships with 2,300+ physicians across 38 states and strategic relationships with 2,600+ dialysis clinics. Their coordinated approach aligns patient and provider needs, reducing hospitalizations, slowing disease progression, and helping people live their best lives while delivering measurable value. The company offers personalized patient support at no additional cost, including access to nurses and dietitians, alongside physician-focused solutions that reduce administrative burden and improve clinician experience. For payers, Interwell Health takes on the total cost of care for this complex population, demonstrating industry-leading results including 85%+ higher home dialysis start rates and approximately 20% fewer all-cause hospitalizations compared to national averages.
Company description Cricket Health official website
Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Cricket Health?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Chronic Kidney Disease (CKD)
- End-Stage Kidney Disease (ESKD)
- kidney disease requiring dialysis
Who it serves
- Accountable Care Organizations
- Dialysis Clinics
- Health Systems
- Nephrology Practices
- Payers
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Recorded integration context: dialysis clinic management systems, EHR systems for nephrology practices.
Geographic context
Markets38 states with in-market physician partnerships · United States (all 50 states)
Company sourceOfficial website
Company milestones
Platform expansion
Formed through merger of Fresenius Health Partners, Interwell Health, and Cricket Health in August 2022. Acquired Acumen Physician Solutions in September 2022. Currently manages 160,000+ lives. Named one of the 'Best Places to Work in Healthcare.'
Partnerships
Recorded partners
- 2,300+ physician partnerships across 38 states
- 2,600+ dialysis clinics
- accountable care organizations
- Eastern Nephrology Associates
- health plans and payers
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Interwell Acumen
EHR and patient management software designed for nephrologists
Software · Cloud SaaSCompany source
Interwell Learning
Educational resources and training for kidney care providers
Service · Cloud SaaSCompany source
Interwell Practice Resources
Practice management tools and resources for nephrology providers
Service · HybridCompany source
Interwell Provider Network
National network of 2,300+ physician partnerships across 38 states
Service · HybridCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Associations between abrupt transition, dialysis-requiring AKI, and early mortality in ESKD among U.S. veterans.BMC nephrology · Nov 14, 2023
Systolic blood pressure, antihypertensive treatment, and cardiovascular and mortality risk in VA nursing home residents.Journal of the American Geriatrics Society · Jul 1, 2023
Clinical Risk Factors For Kidney Tubule Biomarker Abnormalities Among Hypertensive Adults With Reduced eGFR in the SPRINT Trial.American journal of hypertension · Dec 8, 2022
Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease.Diabetes care · Dec 1, 2022
Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C3) study protocol.BMC nephrology · Oct 12, 2022
Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System.JAMA · Sep 6, 2022
Clinical validation
Clinical-trial records
Health Outcomes Patient EducationNCT02976220 · Sponsor · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
85%+ higher home dialysis start rate
compared to national average
~20% fewer all-cause hospitalizations
compared to national average
85% optimal dialysis start rate
at Eastern Nephrology Associates partnership
5x increase in preemptive transplant referrals
at Eastern Nephrology Associates partnership
National Performance Metrics
Value-based kidney care delivery across national network
85%+ higher home dialysis start rate than national average, ~20% fewer all-cause hospitalizations than national average, 600,000+ patients served
Alice (Patient Case Study)
Late-stage kidney disease management and dialysis avoidance through coordinated care support
Successfully avoided dialysis through personalized support from nurses and dietitians at no additional cost
Eastern Nephrology Associates
Transformation to value-based kidney care model to improve patient outcomes and quality metrics
85% optimal dialysis start rate, nearly five-fold increase in preemptive transplant referrals, leading scores in government's value-based kidney care model
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Tommy O'Connor
Chief Executive Officer
David Pollack
President & Chief Operating Officer
Dr. Carney Taylor
Chief Medical Officer
Adriana Day
Chief Financial Officer
Clark Curtis
Chief People Officer
Andrés Reyes
General Counsel
Naz Urooj
Senior Vice President, Quality and Clinical Documentation
Sam Gopal
Senior Vice President, Product & Technology
06 · Company updates
Updates from Cricket Health
Recent articles published on Cricket Health's official website.
Proven Strategies for Value-Based Kidney Care Success
Read on Cricket HealthInterwell Health CEO on Leading with Clarity and Bringing Care Closer to the Patient
Read on Cricket HealthWebinar: AI in Action: Proven Solutions for Kidney Care
Read on Cricket HealthInside Interwell: Dr. Carney Taylor on Pioneering the Future of Kidney Care
Read on Cricket HealthValue-Based Care for Payers
Read on Cricket Health07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Chronic Disease Management & Digital Therapeutics
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.